Drone Certification Test46 Biggest Movers From Yesterday

December 20, 2021by helo-10
https://coreheli.com/wp-content/uploads/2021/12/yesterdays_movers_351.png


Gainers

  • Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday.
  • CMC Materials, Inc. (NASDAQ: CCMP) climbed 33.9% to close at $195.50 on Wednesday after the company announced it will be acquired by Entegris for $6.5 billion in cash and stock.
  • Biofrontera Inc. (NASDAQ: BFRI) shares jumped 26.4% to settle at $6.95 on Wednesday after Benchmark initiated coverage on the stock with a Buy rating and announced a $11 price target.
  • Regional Health Properties, Inc. (NYSE: RHE) gained 23.8% to close at $6.70.
  • Regional Health Props, last month, posted a Q3 loss of $1.25 per share.
  • Gemini Therapeutics, Inc. (NASDAQ: GMTX) rose 23.1% to settle at $2.99 after HC Wainwright & Co initiated coverage on the stock with a Buy rating and a $20 price target.
  • CN Energy Group. Inc. (NASDAQ: CNEY) jumped 22.4% to close at $3.01.
  • Mesoblast Limited (NASDAQ: MESO) climbed 19.2% to settle at $4.97. Mesoblast shares dropped around 28% on Tuesday after the company was notified by Novartis that it has chosen to terminate the agreement with Mesoblast prior to closing.
  • Broadstone Acquisition Corp. (NYSE: BSN) gained 19.1% to close at $10.68.
  • Cabaletta Bio, Inc. (NASDAQ: CABA) jumped 18.2% to settle at $3.97.
  • Ensysce Biosciences, Inc. (NASDAQ: ENSC) surged 17.4% to close at $4.11. Ensysce Biosciences said that the first patients have been enrolled in Phase 1 study of PF614-MPAR, its unique technology platform to provide opioid overdose protection.
  • Trio-Tech International (NYSE: TRT) gained 16.6% to close at $9.42.
  • Aerovate Therapeutics, Inc. (NASDAQ: AVTE) jumped 16.3% to close at $12.34 after the company announced the initiation of its IMPAHCT Phase 2b/Phase 3 trial of AV-101 In Pulmonary Arterial Hypertension.
  • Optical Cable Corporation (NASDAQ: OCC) gained 16.2% to settle at $6.40.
  • Conn’s, Inc. (NASDAQ: CONN) rose 16.1% to close at $20.81. Conn’s Board of Directors authorized a repurchase program of $150 million of its outstanding stock.
  • Design Therapeutics, Inc. (NASDAQ: DSGN) surged 16% to settle at $20.36.
  • Bird Global, Inc. (NYSE: BRDS) gained 15.7% to close at $8.97.
  • VerifyMe, Inc. (NASDAQ: VRME) jumped 13.7% to close at $3.65.
  • East Stone Acquisition Corporation (NASDAQ: ESSC) gained 12.9% to close at $15.24 after declining 26% on Tuesday.
  • Vir Biotechnology, Inc. (NASDAQ: VIR) gained 12.1% to close at $51.62 after the company announced new preclinical data demonstrating the impact of the significant antigenic shift of the new SARS-CoV-2 Omicron variant.
  • SeaChange International, Inc. (NASDAQ: SEAC) rose 11.9% to close at $1.69 after the company reported better-than-expected Q3 results.
  • Nxt-ID, Inc. (NASDAQ: NXTD) shares rose 11.7% to close at $2.78 after the company said it was awarded U.S. General Services Administration contract to distribute personal emergency response systems to Federal, State and Local government purchasers.
  • Tandem Diabetes Care, Inc. (NASDAQ: TNDM) climbed 10.5% to close at $144.34.
  • Eli Lilly and Company (NYSE: LLY) climbed 10.4% to close at $275.28 after the company issued FY21 EPS guidance above analyst estimates.
  • Borr Drilling Limited (NYSE: BORR) gained 9.2% to close at $1.67 after declining over 4% on Tuesday..
  • Galera Therapeutics, Inc. (NASDAQ: GRTX) gained 7.4% to close at $2.90 after BTIG upgraded the stock from Neutral to Buy and announced a $15 price target. Galera Therapeutics shares jumped around 96% on Tuesday after the company announced the primary endpoint met statistical significance in corrected topline efficacy data of Phase 3 ROMAN trial of avasopasem.

Check out these big penny stock gainers and losers

Losers

  • Atai Life Sciences N.V. (NASDAQ: ATAI) dropped 31.9% to close at $6.82 on Wednesday.
  • China Xiangtai Food Co., Ltd. (NASDAQ: PLIN) fell 28.2% to settle at $1.81. The company earlier announced the completion of its first purchase of spot Bitcoin miners worth $7 million.
  • Aspen Group, Inc. (NASDAQ: ASPU) shares declined 27.2% to close at $1.90 on Wednesday after the company reported worse-than-expected Q2 results and cut FY22 guidance.
  • REV Group, Inc. (NYSE: REVG) fell 25.5% to close at $11.87 after the company reported worse-than-expected Q4 EPS and sales results and issued FY22 sales guidance below estimates.
  • Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) shares dipped 25.3% to close at $0.6501 on Wednesday after the company announced tilsotolimod updates. The company said no further enrollment in ILLUMINATE-206 trial is planned at this point.
  • LianBio (NASDAQ: LIAN) fell 21.3% to close at $7.68. LianBio reported a Q3 loss of $0.63 per share.
  • The Oncology Institute, Inc. (NASDAQ: TOI) fell 17.9% to close at $6.25.
  • Alzamend Neuro, Inc. (NASDAQ: ALZN) fell 15.9% to close at $2.59 after jumping 28% on Tuesday.
  • LogicBio Therapeutics, Inc (NASDAQ: LOGC) dropped 15.5% to close at $2.45. Barclays maintained LogicBio Therapeutics with an Overweight and lowered the price target from $24 to $8.
  • Legend Biotech Corporation (NASDAQ: LEGN) shares fell 15.3% to close at $41.14 after the company reported an offering of $300 million in ADSs.
  • Huadi International Group Co., Ltd. (NASDAQ: HUDI) fell 15% to close at $27.62.
  • iSpecimen Inc. (NASDAQ: ISPC) fell 13.3% to close at $10.87.
  • MIND Technology, Inc. (NASDAQ: MIND) shares fell 12.9% to close at $1.55. MIND Technology shares gained 30% on Tuesday after the company reported it entered into a Cooperative Research and Development Agreement with the United States Navy’s Naval Surface Warfare Center, Panama City Division.
  • Adagio Therapeutics, Inc. (NASDAQ: ADGI) fell 12.5% to close at $6.35 after Stifel downgraded the stock from Buy to Hold and lowered the price target from $50 to $9. Adagio Therapeutics shares dipped 79% on Tuesday after the company said based on the in vitro findings related to Omicron, it plans to pause patient recruitment in its Phase 2/3 COVID-19 treatment trial at clinical sites in South Africa.
  • Zai Lab Limited (NASDAQ: ZLAB) fell 12.4% to close at $54.90.
  • Cerence Inc. (NASDAQ: CRNC) dropped 11.4% to close at $69.20. Cerence’s board promoted Dr. Stefan Ortmanns to Chief Executive Officer and Director.
  • ABM Industries Incorporated (NYSE: ABM) fell 11% to close at $40.88 as the company reported fourth-quarter revenue growth of 14.2% year-over-year to $1.69 billion, comprised of 7.4% organic growth and 6.8% from acquisition.
  • BeiGene, Ltd. (NASDAQ: BGNE) fell 10.7% to close at $248.56. BeiGene reported authorisation of BRUKINSA (zanubrutinib) from the UK’s MHRA for the treatment of adults with Waldenström’s Macroglobulinemia in Great Britain.
  • Cooper-Standard Holdings Inc. (NYSE: CPS) fell 7.1% to close at $19.71.
  • Nisun International Enterprise Development Group Co., Ltd (NASDAQ: NISN) fell 6.9% to close at $3.50.
  • I-Mab (NASDAQ: IMAB) fell 5% to close at $46.97. I-Mab received IND approval for Phase 1 clinical trial of bispecific antibody TJ-CD4B in solid tumors in China.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

There is more to being a drone pilot than just buying a machine and flying in your backyard. It can be that simple, but most of us will need to understand some drone laws before we try to take to the sky.

SUBSCRIBE NOW

[contact-form-7 id=”300″ title=”Subscribe form”]
Objectively innovate empowered manufactured products whereas parallel platforms.